Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sook-Bin Woo, D.M.D., B.D.S.

Concepts

This page shows the publications Sook-Bin Woo has written about Diphosphonates.
Connection Strength

3.627
  1. Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws. Biol Blood Marrow Transplant. 2016 Feb; 22(2):344-348.
    View in: PubMed
    Score: 0.409
  2. Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May; 109(5):753-64.
    View in: PubMed
    Score: 0.282
  3. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc. 2009 Jul; 140(7):864-75.
    View in: PubMed
    Score: 0.267
  4. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg. 2009 Mar; 67(3):593-601.
    View in: PubMed
    Score: 0.261
  5. Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification". Oral Oncol. 2009 Aug; 45(8):740.
    View in: PubMed
    Score: 0.257
  6. Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun; 105(6):e1-4.
    View in: PubMed
    Score: 0.246
  7. Biophosphonate-related osteonecrosis of the jaws. Dent Clin North Am. 2008 Jan; 52(1):111-28, ix.
    View in: PubMed
    Score: 0.241
  8. Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions. J Natl Cancer Inst. 2007 Jul 04; 99(13):986-7.
    View in: PubMed
    Score: 0.233
  9. Osteonecrosis of the jaws and bisphosphonates. Alpha Omegan. 2007; 100(4):194-202.
    View in: PubMed
    Score: 0.225
  10. Images in clinical medicine. Bisphosphonate-associated osteonecrosis of the jaw. N Engl J Med. 2006 Nov 30; 355(22):2348.
    View in: PubMed
    Score: 0.224
  11. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006 May 16; 144(10):753-61.
    View in: PubMed
    Score: 0.215
  12. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc. 2005 Dec; 136(12):1658-68.
    View in: PubMed
    Score: 0.209
  13. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005 Jul 07; 353(1):99-102; discussion 99-102.
    View in: PubMed
    Score: 0.203
  14. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist. 2011; 16(1):121-32.
    View in: PubMed
    Score: 0.074
  15. A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer. 2010 Aug; 18(8):1099-106.
    View in: PubMed
    Score: 0.071
  16. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2008 Jun; 66(6):1320-1; author reply 1321-2.
    View in: PubMed
    Score: 0.062
  17. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res. 2008 Apr 15; 14(8):2387-95.
    View in: PubMed
    Score: 0.061
  18. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007 Oct; 22(10):1479-91.
    View in: PubMed
    Score: 0.059
  19. Possible pathogenic engagement of soluble Semaphorin 4D produced by ?dT cells in medication-related osteonecrosis of the jaw (MRONJ). Biochem Biophys Res Commun. 2016 Nov 04; 480(1):42-47.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.